UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1379-1389

2020

Volltextzugriff (PDF)

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

PLoS pathogens, 2017-05, Vol.13 (5), p.e1006373-e1006373

2017

Volltextzugriff (PDF)

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

Clinical infectious diseases, 2021-07, Vol.73 (2), p.e485-e493

2021

Volltextzugriff (PDF)

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Journal of the International AIDS Society, 2017, Vol.20 (1), p.22146-n/a

2017

Volltextzugriff (PDF)

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

The Journal of infectious diseases, 2022-05, Vol.225 (10), p.1688-1693

2022

Volltextzugriff (PDF)

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2429-2438

2012

Volltextzugriff (PDF)

Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era

Clinical infectious diseases, 2021-09, Vol.73 (5), p.e1222-e1227

2021

Volltextzugriff (PDF)

Late HIV diagnosis: Where we stand and the way forward

HIV medicine, 2022-12, Vol.23 (11), p.1115-1117

2022

Volltextzugriff (PDF)

HIV-related stigma within communities of gay men: a literature review

AIDS care, 2012-04, Vol.24 (4), p.405-412

2012

Volltextzugriff (PDF)

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

The Lancet (British edition), 2015-03, Vol.385 (9973), p.1098-1106

2015

Volltextzugriff (PDF)

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

EClinicalMedicine, 2021-10, Vol.40, p.101116-101116, Article 101116

2021

Volltextzugriff (PDF)

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

The Lancet infectious diseases, 2012-02, Vol.12 (2), p.111-118

2012

Volltextzugriff (PDF)

The way forward in HCV treatment - finding the right path

Nature reviews. Drug discovery, 2007-12, Vol.6 (12), p.991-1000

2007

Volltextzugriff (PDF)

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

PloS one, 2022-05, Vol.17 (5), p.e0267853-e0267853

2022

Volltextzugriff (PDF)

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study

PloS one, 2011-03, Vol.6 (3), p.e17781-e17781

2011

Volltextzugriff (PDF)

Late presentation of chronic viral hepatitis for medical care: a consensus definition

BMC medicine, 2017-05, Vol.15 (1), p.92-92, Article 92

2017

Volltextzugriff (PDF)

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

The New England journal of medicine, 2004-07, Vol.351 (5), p.438-450

2004

Volltextzugriff (PDF)

Implementation of EACS vaccination recommendations among people living with HIV

Infection, 2022-12, Vol.50 (6), p.1491-1497

2022

Volltextzugriff (PDF)

Living donor liver transplant from an HIV-positive individual to an HIV-negative individual: could this become a new reality?

AIDS (London), 2018-10, Vol.32 (16), p.2423-2424

2018

Volltextzugriff (PDF)

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

Clinical infectious diseases, 2016-09, Vol.63 (6), p.821-829

2016

Volltextzugriff (PDF)

Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4117-4123

2012

Volltextzugriff (PDF)

Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2005-09, Vol.192 (6), p.992-1002

2005

Volltextzugriff (PDF)

Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation

AIDS (London), 2023-08, Vol.37 (10), p.1573-1581

2023

Volltextzugriff (PDF)

Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men

PloS one, 2019-01, Vol.14 (1), p.e0210179-e0210179

2019

Volltextzugriff (PDF)

1 – 25 von 378

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(351)
Mit Volltextzugriff
(322)

Publikationsform

Sprache

Englisch
(363)
Deutsch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(286)
Life Sciences & Biomedicine
(277)
Humans
(256)
Infectious Diseases
(210)
Male
(158)
Hiv
(156)
Adult
(138)
Female
(127)
Human Immunodeficiency Virus
(119)
Middle Aged
(118)
Hiv Infections - Drug Therapy
(115)
Immunology
(101)
Biological And Medical Sciences
(100)
Medical Sciences
(98)
Hiv Infections - Complications
(87)
Viral Diseases
(84)
Virology
(79)
Human Viral Diseases
(76)
Hepatitis C
(64)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(61)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era

Late HIV diagnosis: Where we stand and the way forward

HIV-related stigma within communities of gay men: a literature review

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

The way forward in HCV treatment - finding the right path

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study

Late presentation of chronic viral hepatitis for medical care: a consensus definition

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

Implementation of EACS vaccination recommendations among people living with HIV

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial

Living donor liver transplant from an HIV-positive individual to an HIV-negative individual: could this become a new reality?

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study

Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy

Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation

Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men

Suchergebnisse filtern